Skip to main content
. 2020 Feb 17;117(1):188–200. doi: 10.1093/cvr/cvaa017

Figure 3.

Figure 3

MMP-2 levels and activity in the ventricle and plasma from DXR mice treated with MMP inhibitors. (A and B) DXR increased MMP-2 protein levels (n = 8) and activity (n = 10) in the heart, which were prevented by Doxy or ONO. (C and D) The plasma from DXR-treated mice exhibited increased levels of MMP-2 protein (n = 7–8) and activity (n = 9–10), which were reduced by ONO. *P < 0.05 by one-way ANOVA followed by the Sidak’s post hoc test.